Retatrutide is a triple agonist peptide studied for its activity on GLP-1, GIP, and glucagon receptors
Consider whether accepting higher weight is preferable to permanent intensive effort, or whether finding financial resources for chronic treatment is possible
Para retatrutida, el paciente ideal tiene sobrepeso u obesidad, busca una prdida de peso significativa y no presenta contraindicaciones graves como pancreatitis activa
Ionescu M, Frohman LA Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog
Please monitor your weight to make sure youre staying in a healthy range
This 48-week, dose-ranging study enrolled adults with obesity and evaluated multiple dose levels of retatrutide against placebo